Invention Grant
- Patent Title: Method of treating abnormal cell growth
- Patent Title (中): 治疗异常细胞生长的方法
-
Application No.: US12095114Application Date: 2006-11-23
-
Publication No.: US07825137B2Publication Date: 2010-11-02
- Inventor: James Gail Christensen , Yahong Zou
- Applicant: James Gail Christensen , Yahong Zou
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Jeffrey H. Tidwell; Stephen D. Prodnuk; Vincent P. Liptak
- International Application: PCT/IB2006/003397 WO 20061123
- International Announcement: WO2007/066187 WO 20070614
- Main IPC: A61K31/454
- IPC: A61K31/454
Abstract:
The present invention relates to the use of (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine, a novel c-Met/HGFR inhibitor, for treating abnormal cell growth in mammals. In particular, the invention provides methods of treating mammals suffering from cancer.
Public/Granted literature
- US20080300273A1 Method of Treating Abnormal Cell Growth Public/Granted day:2008-12-04
Information query
IPC分类:
